Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Sigyn Therapeutics (QB) (SIGY)

Sigyn Therapeutics Inc (QB)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:SIGY
DateTimeSourceHeadlineSymbolCompany
31/01/202421:20Edgar (US Regulatory)Form 8-K - Current reportUSOTC:SIGYSigyn Therapeutics Inc (QB)
30/01/202421:23Edgar (US Regulatory)Form 8-K - Current reportUSOTC:SIGYSigyn Therapeutics Inc (QB)
11/01/202420:25Edgar (US Regulatory)Form 8-K - Current reportUSOTC:SIGYSigyn Therapeutics Inc (QB)
08/01/202419:34Edgar (US Regulatory)Form 8-K - Current reportUSOTC:SIGYSigyn Therapeutics Inc (QB)
12/12/202319:48Edgar (US Regulatory)Form 8-K - Current reportUSOTC:SIGYSigyn Therapeutics Inc (QB)
26/10/202320:23Edgar (US Regulatory)Form 8-K - Current reportUSOTC:SIGYSigyn Therapeutics Inc (QB)
04/10/202322:10Edgar (US Regulatory)Form 8-K - Current reportUSOTC:SIGYSigyn Therapeutics Inc (QB)
19/09/202320:56Edgar (US Regulatory)Form 8-K - Current reportUSOTC:SIGYSigyn Therapeutics Inc (QB)
14/08/202320:35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:SIGYSigyn Therapeutics Inc (QB)
07/07/202316:15Edgar (US Regulatory)Form 8-K - Current reportUSOTC:SIGYSigyn Therapeutics Inc (QB)
08/06/202319:38Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SIGYSigyn Therapeutics Inc (QB)
17/05/202312:15InvestorsHub NewsWireSigyn Therapeutics Discloses "DEVICES FOR ENHANCING THE ACTIVITY OF THERAPEUTIC ANTIBODIES" Patent Submission and Related ImmunePrep™ Trademark ApplicationUSOTC:SIGYSigyn Therapeutics Inc (QB)
15/05/202322:35Edgar (US Regulatory)Quarterly Report (10-q)USOTC:SIGYSigyn Therapeutics Inc (QB)
10/05/202322:27Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:SIGYSigyn Therapeutics Inc (QB)
31/03/202315:06InvestorsHub NewsWireSigyn Therapeutics Announces Filing of 2022 Annual Report on SEC Form 10-KUSOTC:SIGYSigyn Therapeutics Inc (QB)
31/03/202311:19Edgar (US Regulatory)Annual Report (10-k)USOTC:SIGYSigyn Therapeutics Inc (QB)
28/02/202320:19Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:SIGYSigyn Therapeutics Inc (QB)
23/12/202220:52Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:SIGYSigyn Therapeutics Inc (QB)
14/11/202220:51Edgar (US Regulatory)Quarterly Report (10-q)USOTC:SIGYSigyn Therapeutics Inc (QB)
14/09/202217:37InvestorsHub NewsWireSigyn Therapeutics Announces First-In-Human Clinical Strategy to Address Inflammation and Endotoxemia in End-Stage Renal Disease PatientsUSOTC:SIGYSigyn Therapeutics Inc (QB)
30/08/202211:09Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:SIGYSigyn Therapeutics Inc (QB)
15/08/202211:32Edgar (US Regulatory)Quarterly Report (10-q)USOTC:SIGYSigyn Therapeutics Inc (QB)
03/08/202212:07InvestorsHub NewsWireSigyn Therapeutics to Commence Trading on the OTCQB® Venture ExchangeUSOTC:SIGYSigyn Therapeutics Inc (QB)
23/06/202211:02Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:SIGYSigyn Therapeutics Inc (QB)
23/05/202210:00TipRanksAnalysts Are Bullish on These Healthcare Stocks: Sigyn Therapeutics (SIGY)USOTC:SIGYSigyn Therapeutics Inc (QB)
21/03/202221:29Edgar (US Regulatory)Annual Report (10-k)USOTC:SIGYSigyn Therapeutics Inc (QB)
01/03/202222:28Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SIGYSigyn Therapeutics Inc (QB)
04/02/202215:48Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:SIGYSigyn Therapeutics Inc (QB)
17/12/202113:48InvestorsHub NewsWireSigyn Therapeutics CEO Note: As Omicron Surges, Consider That the First Authorized COVID-19 Therapies Were Not Drugs or VaccinesUSOTC:SIGYSigyn Therapeutics Inc (QB)
12/11/202121:49Edgar (US Regulatory)Quarterly Report (10-q)USOTC:SIGYSigyn Therapeutics Inc (QB)
 Showing the most relevant articles for your search:USOTC:SIGY

Your Recent History

Delayed Upgrade Clock